FDA Approves Angiotech's Pulmonary Embolism Device


The FDA approved a pulmonary embolism device to be made by Angiotech Pharmaceuticals Inc. (Nasdaq: ANPI) sending the stock price soaring 65 cents to $2.35.


About this Entry

This page contains a single entry by published on June 8, 2009 10:25 AM.

Human Genome Downgraded was the previous entry in this blog.

Positive Trial Results For Keryx's Zerenex is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12